The A1C test is also called the glycated hemoglobin, glycosylated hemoglobin, hemoglobin A1C or HbA1c test. If you're living with diabetes, the test is also used to monitor how well you're managing blood sugar levels. This device was concluded to have potential for providing faster results and relatively acceptable values to clinicians in need of immediate results. The A1C test is a common blood test used to diagnose type 1 and type 2 diabetes. A very high correlation was observed in glucose, blood urea nitrogen and creatinine ( R>0.975), high correlation was observed in sodium, potassium, Hct and Hb ( R>0.9), and relatively good correlation was observed in chloride and total carbon dioxide ( R>0.7) compared to the central laboratory analysers.Ĭonclusions: i-STAT showed relatively high precision and linearity, and comparable data to that of routine hematology and chemistry analysers. In the aspect of linearity, the correlation coefficient values of all analytes were over 0.975 in the clinically important concentration range. Results: The coefficient of variation values for the within-run precision and total precision at 3 levels of all analytes were within 5%, except those for low level creatinine. Momentary glucose values are constantly changing, thus any momentary value is a poor indicator of. Assuming 134 mg/dL, these are units clinically only used for a momentary value & Is Not the issue with DM. Reference Intervals from Clinical Pathology Laboratory February 2011. 134 a Poor Indicator: 134 likely refers to mg/dL Like all numbers, it has no useful meaning without specifying the units of measurement. 5,200,051, assigned to i-STAT Corporation, uses a thin contiguous analyte. Reference Intervals were established at Iowa State Universitys Clinical Pathology Laboratory. Comparisons with a central laboratory hematology analyser, Coulter LH 780 (Beckman Coulter Inc., USA), and a chemical analyser, UniCel DxC 880i (Beckman Coulter Inc.), were performed using 85 patient samples according to CLSI EP9-A3. Accurate measurement of blood glucose levels would enable the patient to. Methods: The precision and linearity of the 10 analytes were measured according to Clinical and Laboratory Standards Institute (CLSI) EP15-A3 and EP6-A guidelines. Therefore, the aim of this study was to evaluate the performance of the i-STAT POC analyser (Abbott Diagnostics, USA) for testing 8 chemical analytes (viz., sodium, potassium, chloride, total carbon dioxide, blood urea nitrogen, creatinine, glucose, and ionised calcium) and 2 hematological analytes (hematocrit, hemoglobin ). The demand for POCT in the medical field is expanding significantly, given that rapid results can eventually lead to early diagnosis and immediate clinical management of diseases. Background: Point-of-care testing (POCT) is designed to be used near the site where the clinical care is being delivered.

Istat glucose range